Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Taysha Gene Therapies is a patient-centric, clinical-stage gene therapy company dedicated to discovering, developing, and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS). Their approach targets both rare and large patient populations, aiming to provide transformative treatments for severe neurological disorders. The company leverages its deep expertise in gene therapy and CNS diseases to advance a pipeline of innovative candidates.
Serves as the corporate headquarters, overseeing strategic direction, clinical development, financial operations, investor relations, and administrative functions.
Located in a modern office complex in North Dallas, providing a professional environment designed to support collaboration and innovation.
Taysha fosters a science-driven, agile, and patient-focused work environment. The culture emphasizes collaboration, urgency in addressing unmet medical needs, and a commitment to scientific excellence and integrity.
The Dallas headquarters centralizes Taysha's core leadership and operational decision-making, enabling efficient management of its clinical programs and corporate strategy. Its location provides access to a skilled talent pool and business infrastructure.
Taysha Gene Therapies is primarily focused on developing therapies with regulatory strategies targeting major markets like the United States and Europe. Their clinical trials often involve international sites to ensure diverse patient participation. The company actively engages with global patient advocacy groups, researchers, and key opinion leaders to inform and advance its development programs for CNS disorders with worldwide impact.
17877 North Dallas Parkway, Suite 200
Dallas
Texas
USA
Address: Research and Development Facility in Durham (Specific current address for the downsized R&D space not publicly detailed, located in the Research Triangle Park area)
Strategically located in the Research Triangle Park (RTP) area, a prominent global hub for biomedical research, offering access to specialized talent, collaborators, and research infrastructure.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Taysha Gene Therapies' leadership includes:
Taysha Gene Therapies has been backed by several prominent investors over the years, including:
Taysha Gene Therapies has experienced significant leadership updates over the past 12 months, including the appointment of a new CEO, CFO, and COO, reflecting strategic shifts and a focus on advancing its clinical pipeline.
Discover the tools Taysha Gene Therapies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Taysha Gene Therapies typically uses a standard professional email format. The most common structure observed is the first initial of the employee's first name followed by their full last name.
[first_initial][last]@tayshagtx.com
Format
snolan@tayshagtx.com
Example
85%
Success rate
GlobeNewswire • May 13, 2024
Taysha Gene Therapies announced the appointments of Kamran Alam as Chief Financial Officer and Mary Newman as Chief Operating Officer, strengthening its executive leadership team....more
GlobeNewswire • May 13, 2024
Taysha reported its financial results for the first quarter of 2024 and provided updates on its clinical programs, including progress on TSHA-102 for Rett syndrome and TSHA-120 for GAN....more
GlobeNewswire • April 18, 2024
Taysha announced promising clinical data for TSHA-102 in treating Rett syndrome, showing sustained improvements in the low-dose cohort and encouraging initial results from the high-dose cohort....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Taysha Gene Therapies, are just a search away.